BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22605682)

  • 1. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
    Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.
    Lichtenberg M; Stahlhoff W; Boese D
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):433-9. PubMed ID: 24013531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
    Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
    Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.
    Spiliopoulos S; Fragkos G; Katsanos K; Diamantopoulos A; Karnabatidis D; Siablis D
    J Endovasc Ther; 2012 Dec; 19(6):788-96. PubMed ID: 23210878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.
    Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M;
    Trials; 2014 Feb; 15():63. PubMed ID: 24552184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
    Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
    J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifurcated coronary stents for infrapopliteal angioplasty in critical limb ischemia.
    Silingardi R; Tasselli S; Cataldi V; Moratto R; Gennai S; Coppi G; Marcheselli L; Coppi G
    J Vasc Surg; 2013 Apr; 57(4):1006-13. PubMed ID: 23343667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
    Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
    J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up.
    Donas KP; Torsello G; Schwindt A; Schönefeld E; Boldt O; Pitoulias GA
    J Vasc Surg; 2010 Aug; 52(2):356-61. PubMed ID: 20541349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Below-The-Knee Angioplasty for Critical Limb Ischemia: Results of a Series of 157 Procedures and Impact of the Angiosome Concept.
    Pavé M; Benadiba L; Berger L; Gouicem D; Hendricks M; Plissonnier D
    Ann Vasc Surg; 2016 Oct; 36():199-207. PubMed ID: 27427347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up.
    Werner M; Schmidt A; Freyer M; Bausback Y; Bräunlich S; Friedenberger J; Schuster J; Botsios S; Scheinert D; Ulrich M
    J Endovasc Ther; 2012 Feb; 19(1):12-9. PubMed ID: 22313195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal popliteal artery in diabetic patients presenting with critical limb ischemia.
    Taneja M; Tay KH; Dewan A; Sebastian MG; Pasupathy S; Lin SE; Teo T; Lo R; Tan SG; Irani FG; Tan BS
    Cardiovasc Revasc Med; 2010; 11(4):232-5. PubMed ID: 20934655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.